In Reply to "Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective" and "Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups"

Affiliations

Comment

Lesley A Inker et al. Am J Kidney Dis. 2021 May.

. 2021 May;77(5):824.

doi: 10.1053/j.ajkd.2021.01.007. Epub 2021 Feb 8.

No abstract available

Comment on

A New Panel-Estimated GFR, Including β₂-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population.
Inker LA, Couture SJ, Tighiouart H, Abraham AG, Beck GJ, Feldman HI, Greene T, Gudnason V, Karger AB, Eckfeldt JH, Kasiske BL, Mauer M, Navis G, Poggio ED, Rossing P, Shlipak MG, Levey AS; CKD-EPI GFR Collaborators. Inker LA, et al. Am J Kidney Dis. 2021 May;77(5):673-683.e1. doi: 10.1053/j.ajkd.2020.11.005. Epub 2020 Dec 7. Am J Kidney Dis. 2021. PMID: 33301877 Free PMC article.
Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective.
Grubb A, Christensson A, Björk J. Grubb A, et al. Am J Kidney Dis. 2021 May;77(5):823. doi: 10.1053/j.ajkd.2020.12.015. Epub 2021 Feb 8. Am J Kidney Dis. 2021. PMID: 33571579 No abstract available.
Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups.
Delanaye P, Mariat C. Delanaye P, et al. Am J Kidney Dis. 2021 May;77(5):823-824. doi: 10.1053/j.ajkd.2020.12.016. Epub 2021 Feb 8. Am J Kidney Dis. 2021. PMID: 33571580 No abstract available.